Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WILSON, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WILSON, P. D.
J Am Soc Nephrol 12:834-845, 2001
© 2001 American Society of Nephrology


REVIEW

Polycystin: New Aspects of Structure, Function, and Regulation

PATRICIA D. WILSON

Mount Sinai School of Medicine, New York, New York.

Correspondence to Dr. Patricia D. Wilson, Department of Medicine/Division of Nephrology, Mount Sinai School of Medicine, 1425 Madison Avenue, New York, NY 10029. Phone: 212-659-9383; Fax: 212-849-2434; E-mail: pat.wilson{at}mssm.edu


    Abstract
 Top
 Abstract
 Introduction
 Structure of Polycystin-1
 Function of Polycystin-1
 Regulation of Polycystin-1
 Structure of Polycystin-2
 Function of Polycystin-2
 Conclusions
 References
 
Abstract. Polycystin-1 is a modular membrane protein with a long extracellular N-terminal portion that bears several ligand-binding domains, 11 transmembrane domains, and a >=200 amino acid intracellular C-terminal portion with several phosphorylation signaling sites. Polycystin-1 is highly expressed in the basal membranes of ureteric bud epithelia during early development of the metanephric kidney, and disruption of the PKD1 gene in mice leads to cystic kidneys and embryonic or perinatal death. It is proposed that polycystin-1 functions as a matrix receptor to link the extracellular matrix to the actin cytoskeleton via focal adhesion proteins. Co-localization, co-sedimentation, and co-immunoprecipitation studies show that polycystin-1 forms multiprotein complexes with {alpha}2ß1-integrin, talin, vinculin, paxillin, p130cas, focal adhesion kinase, and c-src in normal human fetal collecting tubules and sub-confluent epithelial cultures. In normal adult kidneys and confluent epithelial cultures, polycystin-1 is downregulated and forms complexes with the cell-cell adherens junction proteins E-cadherin and ß-, {gamma}-, and {alpha}-catenin. Polycystin-1 activation at the cell membrane leads to intracellular signaling via phosphorylation through the c-Jun terminal kinase and wnt pathways leading to activation of AP-1 and TCF/LEF-dependent genes, respectively. The C-terminal of polcystin-1 has been shown to be phosphorylated by c-src at Y4237, by protein kinase A at S4252, and by focal adhesion kinase and protein kinase X at yet-to-be identified residues. Inhibition of tyrosine phosphorylation or increased cellular calcium increases polycystin-1 focal adhesion complexes versus polycystin-1 adherens junction complexes, whereas disruption of the actin cytoskeleton dissociates all polycystin-1 complexes. Genetic evidence suggests that PKD1, PKD2, NPHP1, and tensin are in the same pathway.


    Introduction
 Top
 Abstract
 Introduction
 Structure of Polycystin-1
 Function of Polycystin-1
 Regulation of Polycystin-1
 Structure of Polycystin-2
 Function of Polycystin-2
 Conclusions
 References
 
Autosomal dominant polycystic kidney disease (ADPKD) is the most common, lethal, monogenic disease inherited as a dominant trait in humans, occurring with a frequency of 1:500, affecting 500,000 individuals in the United States and 4 to 6 million worldwide, and leading to end-stage renal disease in 50% of those who inherit a single, mutated PKD gene (1,2). In 85% of patients, the gene responsible for disease is PKD1, whereas in 5 to 10% of patients, the mutation is in the PKD2 gene and is usually associated with a slower clinical deterioration of kidney function (3,4,5). A very small percentage of patients have ADPKD that is not associated with either PKD1 or PKD2 mutations. Although an additional close PKD2 homologue, PKDL, has been cloned in mice and deletions have been shown to be associated with kidney defects (6), this has not been identified as the putative human PKD3.

The major ADPKD disease gene, PKD1, on human chromosome 16p13.3 was the first to be identified and shown to have 46 exons and to encode a 14.5-kb transcript (7). Cloning of the full-length cDNA predicted a large, 4303 amino acid protein, termed polycystin-1, which was unique in terms of its modular structure and hydropathy characteristics (8,9). Since that time, it has become clear that polycystin-1 is a member of an ancient and conserved family of proteins that includes the PKD2-encoded protein polycystin-2, as well as homologues in the mouse, the Fugu fish, the sea urchin, and the worm Caenorhabditis elegans (10,11,12,13). Recently obtained molecular, cellular, and biochemical information has led to important insights into the function of the polycystins. Similar studies are beginning to shed light on how polycystin function can be regulated, an important prerequisite for therapy to restore polycystin function to normal in ADPKD patients.


    Structure of Polycystin-1
 Top
 Abstract
 Introduction
 Structure of Polycystin-1
 Function of Polycystin-1
 Regulation of Polycystin-1
 Structure of Polycystin-2
 Function of Polycystin-2
 Conclusions
 References
 
Analysis of the amino acid sequence deduced from the cloned full-length cDNA of human polycystin-1 together with hydropathy profiles predicted that polycystin-1 would be a large-membrane protein of 4303 amino acids, >=462 kD with its N-terminal extracellular and C-terminal intracellular (Figure 1). The presence of a signal sequence suggested that the protein would be synthesized and processed through the secretory pathway of the cell, and hydropathy plot analysis suggested 9 to 11 transmembrane spanning regions (8,14). These predictions of membrane insertion of polycystin-1 have since been confirmed by many investigators using a variety of anti-poly-cystin-1 antibodies or epitope-tagged transfected cDNA and labeled proteins (15,16,17).



View larger version (24K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. Predicted modular structure of polycystin-1 based on the cDNA sequence.

 

Extracellular Domain
After clipping of a characteristic signal sequence at the N-terminal of the protein, the first >3000 amino acids form a long extracellular portion that contains several putative structural domains. The first of these is two cysteine-flanked, leucine-rich repeats that, when present in other proteins, are known to be associated with protein-protein interactions involved in adhesion. Typically, however, leucine-rich repeats occur in much larger multiples than the two found in polycystin-1. For instance, there are 21 or more in the Drosophila Toll protein, decorin, and biglycan (18). Cysteine-rich flanking is typical of extracellular proteins. The next putative domain is homologous to a C-type lectin motif that predicts protein-carbohydrate interactions, because they are found in proteins such as the selectins (19). An interesting property of C-type lectins is their calcium sensitivity. The presence of a 40 amino acid cysteine-rich low-density lipoprotein (LDL-A) homologous domain in the N-terminal of polycystin-1 is difficult to interpret, although this type of hydrophobic extracellular domain has been implicated in ligand binding.

A distinctive and unique feature of polycystin-1 is the presence of 16 copies of the so-called "Ig-like" PKD domains. The first PKD repeat is located between the C-lectin and LDL-A domains; the rest are located after the LDL-A domain and are linked by 5 to 7 amino acid spacers (see Figure 1). Although the overall homology to immunoglobulins and to one another is low, there is a conserved portion of sequence (WDFGDGS) in all human PKD domains. Nuclear magnetic resonance structural analysis of PKD repeat number 10, which is conserved from human to Fugu fish, revealed an Ig-like ß-sandwich fold, again implicating a role in ligand binding for the extracellular portion of the polycystin-1 protein (20). Overall, these structural sequence analysis studies suggest that the long N-terminal portion of polycystin-1 might be capable of binding one or more ligands in the extracellular compartment. Supportive evidence of this notion includes the finding that polycystin-1—containing epithelia specifically bind type I collagen (21).

The most distal specifiable domain in the extracellular portion of the polycystin-1 protein is a 1000 amino acid sequence that shows high homology to the sea urchin receptor for egg jelly (REJ) (11). Recently, additional family members of REJ have been identified in the human testis (9). Although the function of this domain in the polycystin-1 protein remains obscure, it should be noted that in sea urchin it is involved in the acrosome reaction during which, after the attachment of the sperm, a calcium flux is generated and leads to remodeling of the sperm membrane to facilitate binding. It is possible, therefore, to speculate that there is a similar calcium influx role for this portion of the membrane protein in polycystin-1.

Transmembrane Domain
Hydropathy plot and computer-assisted analyses identified 9 to 11 transmembrane regions from amino acid 3075 to 4104 (or 4014) with intervening intracellular and extracellular loops (8,14; C. R. Burrow, personal communication). The uncertainty in the literature, including suggestions that there are as few as seven transmembrane domains, is a reflection of the limitation of computer algorithms and emphasizes the need for direct biochemical protein purification and crystallization studies to elucidate definitively the structure. Nevertheless, computer-assisted analysis carried out since the elucidation of the cDNA and predicted amino acid sequence has provided strong clues and allowed hypotheses relating to the structure and function of the protein to be constructed and tested. One such strong hypothesis was that polycystin-1 would prove to be a membrane protein; this has been borne out by several immunolocalization studies (15,16,17,21,22,23,24,25,26).

As yet unknown and untested are the significance of motifs present in the intervening loops between transmembrane domains 1 and 11. Of potential interest are a tyrosine at amino acid position 3614 (14) in an intracellular loop between membrane spans 5 and 6 and a proline-rich sequence at 3524 in an intracellular loop between membrane spans 3 and 4, consistent with a consensus sequence for a src homology 3 (SH3) binding site (27). Both of these suggest possibilities for signal transduction function of the protein.

Intracellular Domain
The C-terminal 200 (or 226) amino acids of polycystin-1 form the most distal, intracellular portion of the molecule and contain numerous potential phosphorylation sites, some of them in well-characterized consensus sequences of known signaling molecules. A putative role for polycystin-1 in intracellular signal transduction is highly predicted for this portion of the molecule because of the presence in an intracellular C-terminal portion of the protein of four tyrosines, one in a consensus sequence for an SH2 domain-containing protein binding site (28). In addition, among the several serines and threonines contained within this 200 amino acid portion, there are two consensus RSSR sequences in the human protein at 4162 to 4167 and 4250 to 4253, which are consistent with target sites for phosphorylation by protein kinase A (PKA) or C (PKC) (28). Other putative domains known to be involved in signaling functions include a proline-rich sequence consistent with a putative WW site (29) and a heterotrimeric G protein activation sequence (30). Also of interest, the C-terminal portion of polycystin-1 contains a putative coiled-coil region (human amino acids 4193 to 4248), which is a motif of bundles of {alpha}-helices wound into a superhelix with knobs into holes packing geometry, first identified in 1953 by Pauling and Cory in fibrous proteins and later also in the dimerization elements of the leucine zipper class of transcription factors (see reference 31 for review). Coiled coils are also found in the vesicle fusion molecules SNARES, synaptobrevin, and SNAP, which play an important role in membrane protein trafficking. This allows the speculation that mutations that truncate this portion of polycystin-1 protein might be responsible for mispolarization of membrane proteins demonstrated in ADPKD epithelia (16,32,33,34,35). The presence of this type of coiled-coil motif in the C-terminal portion of polycystin-1 (and polycystin-2) strongly predicted protein-protein interactions, and experimental analysis using yeast 2-hybrid and overexpression techniques have been used to confirm this possibility. For instance, the coiled-coil region of polycystin-1 has been shown to bind polycystin-2 in vitro at least in cell-free systems or after transfection and expression at an unphysiologically high level (36,37). Therefore, these studies show a capability for these two polycystins to bind, but proof will await comprehensive immunolocalization studies in vivo, which have begun and suggest that although polycystin-1 and polycystin-2 occasionally co-localize, they often do not (25,26).


    Function of Polycystin-1
 Top
 Abstract
 Introduction
 Structure of Polycystin-1
 Function of Polycystin-1
 Regulation of Polycystin-1
 Structure of Polycystin-2
 Function of Polycystin-2
 Conclusions
 References
 
Several approaches have been used to attempt to elucidate the function of polycystin-1 function, including determining expression levels of mRNA and protein, tissue, and cellular and subcellular distribution patterns and biochemical and molecular analyses.

Expression
The tissue and cellular and subcellular distribution of proteins provides a first line of interpretation of putative protein function. Several studies have used anti-polycystin-1 antibodies (15,16,17,21,22,23,24,38,39) and cDNA as probes (7,16). Despite some discrepancies probably relating to individual monoclonal and polyclonal antibodies raised against various epitopes and peptide sequences in the large protein, the following general conclusions can be drawn: polycystin-1 has a fairly wide tissue distribution, being highly expressed in kidney, brain, liver, pancreas, heart, intestine, and several cell lines. Of particular interest, there is strong evidence of developmental regulation of polycystin-1 in the kidney (23,24,38,40). The functional significance of developmental regulation is borne out by the perinatal lethality of targeted mouse PKD1 mutants with an 836 residue truncation due to enormously cystic kidneys (41). Even more compelling is the report that heterozygotes for this targeted disruption of polycystin-1 developed cystic kidneys in mid-life, which models the typical pattern of disease seen in human ADPKD (42). Other mutations in the PKD1 gene that lead to a larger truncation lead to embryonic lethality, as do those in PKD2 (43,44). Taken together, these studies prove that polycystin-1 plays an essential role in the development and differentiation of normal kidney architecture and function.

The cellular and subcellular distribution patterns of polycystin-1 in the human and mouse kidney help to provide clues to determine its function. Polycystin-1 is highly concentrated in the epithelia of the ureteric bud structures in early metanephric kidneys, where it is seen on cell membranes associated with focal densities at the basal membrane in contact with the extracellular matrix of the blastema (16,21) (Figure 2A). Of great interest and significance is that in the adult kidney, not only is there downregulation of polycystin-1 content on a per-gram protein basis (21), but also the localization is predominantly at the cell-cell junctions localized to the opical/lateral aspect of the cells of the medullary collecting duct epithelia (Figure 2B).



View larger version (140K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. Immunohistochemical localization of polycystin-1. (A) Six-wk human fetal mesonephric kidney. Note punctate staining at the basal surface of the epithelium (arrows). (B) Normal adult kidney. Note punctate staining at the apical aspects of the lateral cell membranes in medullary collecting tubule epithelium (arrows). L, lumen. (C) Subconfluent human fetal collecting tubule (HFCT) cell line subjected to immunocytochemistry with anti-polycystin-1 antibody. Note focal areas of reaction product at regions of contact with collagen substrate (arrows). (D) Confluent HFCT cells subjected to immunocytochemistry with anti-polycystin-1 antibody. Note chicken-wire appearance and foci of reaction product at regions of cell-cell contact (arrows).

 

Of importance for functional studies is that we have derived cell strains and lines from normal human fetal renal collecting tubule (HFCT) epithelia that endogenously express high levels of normal polycystin-1, as well as adult normal human kidney collecting tubule cell strains that express low levels (45,46). Using these cell cultures derived from normal epithelia, it is possible to mirror the two types of expression pattern seen in human kidneys in vivo. In subconfluent cultures, where the predominant interactions are between cells and their matrix, there is a focal adhesion pattern of distribution of polycystin-1 at the basal membrane of cells at the interface between the cell contact and the extracellular matrix (Figure 2C). By contrast, in confluent cultures where cell-cell interactions predominate, the distribution pattern of polycystin-1 is predominantly lateral/apical and shows the typical "chicken-wire" appearance (Figure 2D). These studies suggest that during development and maturation, the distribution of polycystin-1 shifts from the initial localization in cell-matrix focal adhesions to the later cell-cell association junctions at the apical aspect of the lateral membranes (47,48). Paradigms exist for proteins that are important and highly expressed in renal development being retained after development to control differentiation (e.g., the Wilms tumor protein). This also seems to be the case for polycystin-1 in normal kidneys, although it has been shown that expression levels and patterns in adult kidneys can also be increased and altered by injury, cytokines, and disease, including acute tubular necrosis and renal tumorigenesis.

Cell Biology of ADPKD
Much has been learned about the cell biologic abnormalities associated with ADPKD in the kidney (see references 16,47,49,50,51 for reviews). Major defects of increased proliferation and apoptosis, ion and fluid secretion, membrane protein mispolarization, cell-matrix and adhesion abnormalities, and underlying persistent fetal gene expression have been demonstrated. Although the individual abnormalities seem diverse, they all are consistent with the role of polycystin-1 as critical in the pleiotropic mechanisms of renal organogenesis, which involve an exquisite coordination of proliferation and apoptosis of renal progenitor cells and tubule epithelia, migration through attachment and disassociation of the ureteric bud epithelium through the metanephric mesenchyme and matrix, differentiation and polarization of membrane proteins in the maturing renal tubule epithelia, and acquisition of ion and fluid-absorptive properties of the maturing nephron.

To coordinate these events and produce a normal kidney, it is clear that numerous genes must be regulated strictly. Recent results have shown that the underlying mechanisms of mispolarized epithelial growth factor receptor (34) and NaK-ATPase membrane proteins (32) in ADPKD kidneys are due to the failure to switch off fetal gene transcription of ErbB2 and the ß-2 subunit of NaK-ATPase, respectively (52,53,54). This has led to the working hypothesis that ADPKD results from the failure of polycystin-1 to regulate gene transcription appropriately as a result of an interference with the activation of normal signal transduction cascades in response to ligand interactions with polycystin-1 at the cell surface (Figure 3). According to this model, in normal conditions during development, polycystin-1 receives information from the extracellular compartment and via phosphorylation events in its C-terminal signals intracellularly to the nucleus regulating gene transcription appropriately. In ADPKD, the lack of appropriate C-terminal—mediated signal transduction cascades would lead to inappropriate regulation of gene transcription and abnormal kidney development. A precedent for this type of matrix-induced signal transduction exists, of course, with regard to the matrix receptors of the integrin family. After interaction with extracellular ligands, integrins cluster and nucleate a group of proteins of the focal adhesion complex, which then activate by phosphorylation via protein tyrosine kinases, such as focal adhesion kinase (FAK) and src, downstream signaling cascades that impact on active gene regulatory protein (AP-1)-dependent gene transcription (55,56,57,58,59)



View larger version (12K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 3. Schematic representation of extracellular matrix to nuclear signalling in normal epithelia (A) and autosomal dominant polycystic kidney disease (ADPKD) epithelia (B).

 

Binding Proteins
Several lines of evidence suggest that polycystin-1 can and does bind to other proteins to form a multiprotein complex at the membranes of cells. Initial studies using in vitro cell-free systems and fusion proteins (yeast 2-hybrid) approaches as well as transfection and forced overexpression in HEK293 cells suggested that polycystin-1 might bind to polycystin-2 and possibly other cytoskeletal proteins in cells (36,37). Although these types of study are highly unphysiologic and prone to false positives, they provide a rapid means of generating hypotheses. Immunohistochemical analysis of polycystin-1 and polycystin-2 in a variety of tissues has confirmed the co-expression of these proteins (25,26).

An in-depth physiologic analysis has been carried out using cell lines that endogenously express normal levels of natural polycystin-1 protein. Double immunofluorescence labeling studies showed that immediately after plating HFCT at low density on type I collagen, polycystin-1 co-localized in a completely overlapping manner with the collagen receptor {alpha}2ß1-integrin and the focal adhesion proteins vinculin and paxillin (21). The sites of co-distribution were at focal adhesion-like accumulations in the focal plane of the basal cell membrane where it contacted the matrix. In a large series of studies in which cell extracts were sedimented over sucrose density gradients, 13 fractions that were collected and analyzed by Western immunoblot and immunoprecipitations established that polycystin-1 not only co-distributes but also co-associates with several "classical" proteins of focal adhesion complexes that form in cells after attachment to matrix via integrins (21,48,60). Taken together, the results of several studies show that the protein present in polycystin-1 complexes include the structural and actin-binding proteins vinculin, talin, tensin, and {alpha}-actinin; the adaptor proteins paxillin and p130cas; and the signaling kinases c-src and FAK (Figure 4A). Polycystin-1 association with this group of proteins is prevalent shortly after cells attach to type I collagen matrix in a subconfluent density, which models the state of ureteric bud cells during development.



View larger version (24K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 4. Schematic representation of polycystin-1—multiprotein complex formation at focal adhesions in basal membranes of ureteric bud epithelia in developing kidneys and in subconfluent HFCT epithelia in vitro (A) and at cell-cell adherens-type junctions in the apical aspects of the lateral membranes in medullary collecting tubule epithelia of normal adult kidneys and in confluent HFCT and normal adult collecting tubule (NHCT) epithelial cells in vitro (B). T, talin; P, paxillin; V, vinculin; F, focal adhesion kinase; S, c-src; C, p130cas; Te, tensin; *, proteins, that when mutant, cause cystic kidney disease; E-C, E-cadherin; {alpha}, {alpha}-catenin; ß, ß-catenin.

 

Focal adhesions are sites of nucleation of intracellular proteins on the cytoplasmic face of the cell membrane and provide a link between the extracellular matrix and the actin cytoskeleton. These have been shown recently to be dynamic structures of varying sizes and regulate cell-matrix interactions, motility, and signal transduction via a complex set of phosphorylation and dephosphorylations of component proteins (61,62,63,64). A critical component of focal adhesions is the nonreceptor tyrosine kinase FAK, which is phosphorylated in response to matrix adhesion via integrin and then regulates phosphorylation of its downstream substrate targets such as paxillin. FAK function has been shown to be determined by its targeting and recruitment to the focal adhesion complex via binding of its C-terminal domain focal adhesion-targeting sequence (65). In light of these findings, it was of great interest to demonstrate that although polycystin-1—containing focal-adhesion multiprotein complexes assembled at the membranes of ADPKD epithelial cells containing a 1227 amino acid truncation, one protein that is always absent from the ADPKD complexes was FAK (21,48). Because, as in all cells, it has been shown that there is free FAK in the cytoplasm of ADPKD epithelial cells, this suggests that the mutant polycystin-1 is specifically unable to recruit FAK to its multiprotein complexes, which is expected to have drastic consequences on downstream signaling.

Confluent normal renal epithelial cells are a model for the state found in normal adult renal epithelia, because polycystin-1 is localized at the apical/lateral cell-cell borders as in normal collecting tubule epithelia in vivo. When co-localization, sedimentation, and precipitation analyses were carried out on normal confluent cells, it was interesting to note that in addition to some focal adhesion protein interactions, polycystin-1 showed major interactions with proteins characteristic of the cell-cell adherens-type junctions, notably, E-cadherin and ß-, {gamma}-, and {alpha}-catenin (48,66) (Figure 4B). The cell-cell adherens-type junctions in renal epithelia are formed at the apical-lateral aspect of cells, just below the tight junctions. E-cadherin molecules from adjacent cells form zipper-like attachments via homophilic calcium-dependent interactions. Each cadherin molecule has a single membrane span, and the highly conserved intercellular domain interacts with ß-catenin, which binds to {alpha}-catenin and perhaps plakoglobin ({gamma}-catenin) to form a link to the actin cytoskeleton via interactions with the actin-binding proteins {alpha}-actinin or vinculin. In addition to its role in adhesion and assembly of adherens junctions, ß-catenin has been shown to play and important role in signaling in the wnt pathway and subsequent regulation of gene transcription. Cellular levels of ß-catenin are downregulated constitutively by a component of the wnt pathway glycogen synthase kinase (GSK)-3ß via phosphorylation found in complexes with adenomatous polyposis coli and axin. When the wnt pathway is activated, GSK-3ß is inactivated, allowing stabilization of ß-catenin, which then translocates into the nucleus and forms a complex with T-cell-specific transcription factor/lymphoid enhancer binding factor (TCF/LEF) transcription factors and activates dependent gene transcription (56,67,68). Thus, ß-catenin has independent roles in adhesion and signal transduction/gene transcription, and, not surprising, plays an important role in many developmental processes (69). This allows the speculation that the same might be true in renal development via its association with polycystin-1. Further studies suggest that polycystin-1 can bind and activate heterotrimeric G proteins at least in vitro (30) and that polycystin-1 can inhibit the degradation of the regulator of G protein signaling protein, RGS7 (70), suggesting a putative role for polycystin-1 in signal transduction.

Signal Transduction
Because the C-terminal portion of the polycystin-1 protein not only interacts with many other proteins but also contains many putative phosphorylation and proline-rich sites indicative of signaling function, several studies have been carried out to identify signal transduction cascades that are activated by polycystin-1. For these types of studies, it is necessary to transfect into cells the C-terminal portion of polycystin-1 and for it to be expressed at the cell membrane, its normal site of action. Walz and colleagues were the first to succeed in this type of study using heterologous constructs in which the C-terminal amino acid sequence of human polycystin-1 was attached to CD16 and CD7 or CD5 sequences to secure insertion into the plasma membrane (71), which, of course, are not present in the normal polycystin-1 protein.

In an attempt to produce a more homologous system, we used constructs with the C-terminal amino acid sequence of human polycystin-1 inserted into the membrane via either a myristoylation signal (found in c-src) or an additional sequence of the last five natural transmembrane domains of polycystin-1 and a preprotrypsin leader sequence for membrane insertion. Both of these constructs were shown to insert into the plasma membrane of transfected cells as detected by FLAG or green fluorescence protein reporter tags. Using this approach we have been able to confirm the findings that polycystin-1 can stimulate AP-1 dependent gene transcription via the c-Jun terminal kinase pathway. We also found that this effect was stimulated by cyclic adenosine monophosphate. Most interesting is that it has also been demonstrated that these effects can be abrogated by dominant negative constructs of the cytoskeletal effector small guanosine triphosphatases (GTPases) rac-1 and cdc-42 as well as by the calcium-dependent PKC{alpha} (71).

In addition to the AP-1-dependent class of genes that is often related to proliferation control, Walz's group showed that TCF-dependent gene transcription can be regulated by polycystin-1 C-terminal via the wnt pathway (72). Polycystin-1 inhibits the phosphorylation of intermediate GSK-ß, which in turn leads to the accumulation and stabilization of ß-catenin, which complexes with the transcription factor TCF and leads to transcriptional activation of TCF-responsive genes. Although these studies should be viewed with some caution because of the heterologous nature of the constructs used and the forced overexpression of the proteins, the correlation with independent studies showing co-sedimentation and co-immunoprecipitation of polycystin-1 with ß-catenin in endogenously expressing cells (48,73) lends credence to the theory that modulation of the Wnt-pathway maybe an important route through which polycystin-1 regulates differentiation-related genes (Figure 5).



View larger version (30K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 5. Schematic representation of polycystin-1-induced intracellular signalling pathways. , phosphorylation.

 


    Regulation of Polycystin-1
 Top
 Abstract
 Introduction
 Structure of Polycystin-1
 Function of Polycystin-1
 Regulation of Polycystin-1
 Structure of Polycystin-2
 Function of Polycystin-2
 Conclusions
 References
 
Actin Cytoskeleton
Independent studies from different groups show that polycystin-1 forms multiprotein complexes at the cell membrane (21,73). Polycystin-1 has been shown to associate with both matrix adhesion-stimulated, integrin-induced focal adhesion complexes and cell-cell adhesion-induced calcium-dependent E-cadherin-ß-catenin complexes in different cell types under different conditions of confluence. Focal adhesions form a bridge between the extracellular matrix and the actin cytoskeleton via the cell membrane while E-cadherin-containing cell-cell adherens junctions form homophilic binding between cells, linking their cell membranes to the actin cytoskeleton via ß-, {gamma}-, and {alpha}-catenin complexes. A regulatory role for the actin cytoskeleton in formation of both types of multiprotein complex was therefore hypothesized and has been demonstrated using co-localization and co-sedimentation analyses (48,74). Cytochalasin D, which depolymerizes actin microfilament, altered cellular architecture and completely disrupted the polycystin-1-containing multiprotein complexes in subconfluent (focal adhesion-complexed) and confluent (cell-cell adherens-complexed) cells. Because colchicine had no effects under the identical conditions, this strongly implicates a role for the actin cytoskeleton in the control of polycystin-1-containing multiprotein complex formation.

Phosphorylation
There are several cytoplasmic phosphorylation sites on the polycystin-1 protein (see Figure 1). Phosphorylation of the endogenous protein in normal HFCT cells was demonstrated directly by immunoprecipitation with polycystin-1 antibody followed by Western immunoblot analysis with antiphosphotyrosine and vice versa (21). In these studies, there was also a suggestion that ADPKD epithelia with truncation mutations in polycystin-1 showed reduced levels of polycystin-1 phosphorylation on tyrosine. A different approach has also implicated a regulatory role for tyrosine phosphorylation in polycystin-1-focal adhesion multiprotein complex formation because the specific inhibitor tyrphostin has been shown to abolish polycystin-1-FAK association. This was demonstrated by sedimentation of cellular proteins over sucrose density gradients followed by co-immunoprecipitation analyses of the separated fractions. After tyrphostin treatment of cells, polycytsin-1 no longer co-immunoprecipitated with FAK (48). By contrast, in tyrphostin-treated HFCT cells, polycystin-1 associated with ß-catenin, suggesting a potential for differential regulation of polycystin-1 complex partners by tyrosine phosphorylation.

To analyze the specific sites of phosphorylation in the C-terminal cytoplasmic portion of polycystin-1, investigators have analyzed C-terminal polycystin-1 fusion proteins in vitro in the human (28) or the mouse (75). Using site-directed mutagenesis, Li et al. (28) analyzed all four tyrosines (Y4110, Y4118, Y4127, Y4237) and the serines in the two PKA/PKC RSSR consensus sequences (S4165/6; S4252/3) by in vitro kinase assays. With the use of either purified or recombinant enzymes as well as endogenous cell lysates, it has been established that c-src, FAK, PKA, and a novel kidney cyclic adenosine monophosphate-dependent kinase protein kinase X can phosphorylate the polycystin-1 C-terminal (28,76). This suggests that both tyrosine and serine/threonine phosphorylation may be important mediators of polycystin-1 function. Most important, the site-directed mutagenesis of single residues of the human protein has identified Y4237 as the specific target site for s-src and S4252 as the specific target site for PKA.

Calcium
Independent lines of evidence have suggested that calcium might play a role in the regulation of polycystin function. The extracellular domain of polycystin-1 contains C-lectin and REJ homology domains, and the intracellular C-terminal of polycystin-2 contains an EF hand, all related to calcium-dependent binding or ion influx. In addition, polycystin-2 can bind a transient receptor channel protein-1 (TRPC-1), which might allow calcium ion influx and intracellular signaling, and AP-1-dependent gene transcription can be modulated by the calcium-dependent kinase PKC{alpha}. Most compelling, perhaps, is the ability of polycystin-1 to form multiprotein complexes with the calcium-dependent E-cadherin; our recent functional studies implicated a direct role for calcium in the regulation of the type of polycystin-1-multiprotein complex associations. Increased calcium concentrations in the media of confluent normal HFCT cells induced increased polycystin-1-E-cadherin-ß-catenin association and decreased polycystin-1-FAK associations (48). This suggests that local calcium concentrations at the cell membrane may regulate differential distribution of polycystin between cell-matrix (integrin-FAK) and cell-cell (E-cadherin-ß-catenin) contacts; the former contacts are predominant during development and migration of the ureteric bud through the metanephric blastema, and the latter are predominant in adult, fully differentiated collecting ducts.


    Structure of Polycystin-2
 Top
 Abstract
 Introduction
 Structure of Polycystin-1
 Function of Polycystin-1
 Regulation of Polycystin-1
 Structure of Polycystin-2
 Function of Polycystin-2
 Conclusions
 References
 
Polycystin-2 is predicted to be a membrane protein with six transmembrane-spanning domains that are homologous (25% identical, 50% similar) to the last six transmembrane domains of polycystin-1 (10). Unlike polycystin-1, however, both the N- and the C-termini of polycystin-2 are predicted to be intracellular. Domains of interest within the cytoplasmic C-terminal portion of polycystin-2 include a putative coiled-coil domain. It should be noted that although in vitro binding and heterologous overexpression studies have shown that the C-terminal coiled-coil portion of polycystin-1 can bind to polycystin-2 to form heterodimers, this is not mediated by the coiled-coil domain in polycystin-2. However, it is thought that polycystin-2 homodimers can form via the polycystin-2 coiled-coil domains (36,37). It has also been shown that polycystin-2 can bind a calcium capacitance entry-type channel encoded by the homolog of the Drosophila gene TRPC-1 (77), which in mammals is known to represent a nonselective, calcium-permeable, cation channel, allowing calcium entry into the cell. In addition, in the C-terminal portion of polycystin-2, an EF hand sequence motif that is typical of calcium binding proteins is found, which suggests a potential to bind calcium. These findings tempt the speculation that calcium might play a role in polycystin function.


    Function of Polycystin-2
 Top
 Abstract
 Introduction
 Structure of Polycystin-1
 Function of Polycystin-1
 Regulation of Polycystin-1
 Structure of Polycystin-2
 Function of Polycystin-2
 Conclusions
 References
 
The function of polycystin-2 is less well understood and studied than polycystin-1. Independent lines of evidence implicate a putative role for polycystin-2 for interaction with polycystin-1 in a large multiprotein complex (25,36,71) and interaction with calcium by binding either via its EF hand motif in the C-terminal or to a TRPC-1 channel (77). However, functional data in normal cells that express endogenous polycystin-2 are lacking. It is of interest, however, that an additional homologue of polycystin-2, polycystin-L, has been cloned and shown to be capable of acting as a nonselective cation channel when injected into Xenopus oocytes (78). A role for renal development is substantiated by the generation of kidney and liver cysts in the homozygous and heterozygous knockout mice for PKD2 (44). These studies taken together with those from the PKD1 knockout mouse suggest that these genes function in the same pathway of renal development and differentiation.

Expression analyses show that polycystin-2 expression is widespread in many tissues and that it is developmentally regulated in the kidney with highest levels in distal tubules (25,26). It is interesting that the renal cysts derived in PKD2 knockout mice also seem to derive from predominantly distal segments of the nephron (44). Most recent results suggest a complex relationship between polycystin-2 and polycystin-1 because although there are some areas of overlap of expression, there are many areas in which polycystin-2 is expressed but polycystin-1 is not, suggesting independent functions. Also, at the subcellular level, although some similar tubular cell types can express both proteins, the basal localization of polycystin-2 in collecting ducts does not overlap with the apical/lateral localization of polycystin-1 (26).

It may be hypothesized that polycystin-2 could have more than one function, dependent on its association with polycystin-1 protein or not. Elucidation of its true function will await further studies that use transfected or endogenously expressing cell lines. A single such study of signal transduction potential showed that polycystin-2, like polycystin-1, can activate AP-1-dependent gene transcription via c-Jun terminal kinase but also via mitogen-activated protein kinase and that this can be modulated by the calcium-independent PKC epsilon (71), again suggesting that polycystin-2 might have an impact on similar downstream targets as polycystin-1 but via different intermediate pathways. Furthermore, PKD2 has been shown to interact with Hax-2, a protein that forms links with the actin cytoskeleton (79), showing further overlap with polycystin-1 targets.


    Conclusions
 Top
 Abstract
 Introduction
 Structure of Polycystin-1
 Function of Polycystin-1
 Regulation of Polycystin-1
 Structure of Polycystin-2
 Function of Polycystin-2
 Conclusions
 References
 
Taken together, published and recent results show that polycystin-1 is a modular membrane protein that has a long extracellular N-terminal portion with several ligand-binding domains, 9 to 11 transmembrane domains, and a >=200 amino acid intracellular C-terminal domain with several phosphorylation sites in known signaling consensus. Cellular and subcellular distribution, developmental regulation, and genetic studies in mice with targeted mutations show that polycystin-1 is essential for normal renal development and that its primary site of action is at the basal membrane focal adhesions of the ureteric bud epithelium. Normal renal development of the metanephric kidney is the result of reciprocal interactions between the migrating and branching ureteric bud and the metanephric blastema composed of mesenchyme and matrix. Several components of the focal adhesion protein complex have been implicated and are necessary for normal migration of cells, including FAK, p130Cas, paxillin, and c-src (64,80,81,82). It now seems that polycystin-1 is part of this complex also and that it, too, is critical for normal migration of the ureteric epithelium through the matrix of the metanephric blastema.

In addition, activation of polcystin-1 seems to regulate at least two sets of genes: AP-1-dependent, which are often involved in regulation of proliferation, and wnt-responsive TCF/LEF genes, also involved in differentiation. These processes, of course, are critical during development, and upstream mutations in components such as polycystin-1 is expected to disrupt gene transcription related to nephrogenesis and differentiation. This is consistent with the findings that ADPKD cellular defects are a consequence of inappropriate persistent fetal gene expression of critical differentiated membrane proteins (49,52,53,54,83).

Because mutations in polycystin-2 cause a disease in humans with an identical phenotype, although maybe a slower progression, it is suggested that these genes work in the same pathway. These conclusions have been verified by the similar renal cystic phenotypes seen in the knockout mice for PKD1 and PKD2. A new paradigm for the understanding of genetic diseases with similar phenotypic outcomes has been established in studies of the genetic basis of muscular dystrophy, in which it has been shown that mutations in dystrophin, sarcoglycans, and laminin-2 all give rise to a type of muscular dystrophy (84,85). Of particular interest, these proteins form a complex that links the extracellular matrix to the actin cytoskeleton. Clear parallels therefore exist with polycystin-1, which forms a complex with focal adhesion proteins to link the extracellular matrix through the cell membrane to the actin cytoskeleton. If the muscular dystrophy paradigm is correct, then mutations in other proteins of the polycystin-1 complex also should lead to cystic kidney disease. This has been established for four components: polycystin-1, polycystin-2, nephrocystin, and tensin (Figure 4A, denoted by *) (4,7,41,44,86,87). Furthermore, an additional protein of the focal adhesion complex {alpha}-actinin-4 has been implicated as a genetic cause of familial focal segmental glomerulosclerosis (88).

If polycystin-1-containing complex function is critical to providing a link between the extracellular matrix and the actin cytoskeleton to lead to development of a normal kidney, it is predicted that the organization and integrity of this cytoskeleton is required. Synthesis and organization of the actin cytoskeleton are under the control of several proteins of the Ras superfamily, including the small GTPases rac, rho, and cdc-42. Of interest, dominant negative rac-1 and cdc-42 abrogated polycystin-1-dependent AP-1 activation (71). This family of small GTPases also plays critical roles in cell polarity and adhesion during cell migration (89). Further evidence for the involvement of the actin cytoskeleton in normal polycystin-1 function is the complete disruption of polycystin-1-containing complexes by cytochalasin D, showing the necessity of an intact actin cytoskeleton for function in a multiprotein complex (48).

The current body of evidence suggests that polycystin-1 functions normally at the cell membrane by forming multiprotein complexes and receives input from ligand interactions in the extracellular matrix (or on other cells), becomes phosphorylated, and regulates a phosphorylation cascade of activation of intracellular signaling through its C-terminal intracellular portion. Truncation mutations that fail to signal appropriately seem to fail to recruit the normal complement of proteins, lacking FAK, and subsequently fail to downregulate fetal gene transcription and thereby allow the postnatal expression of fetal proteins associated with the cell biology and pathophysiology of ADPKD, notably altered matrix adhesion, ion and fluid secretion, and increased epithelial cell proliferation. Our view is that polycystin-1 acts as a type of master regulator of cell function through its ability to assemble large signaling complexes and activate several signaling pathways.


    References
 Top
 Abstract
 Introduction
 Structure of Polycystin-1
 Function of Polycystin-1
 Regulation of Polycystin-1
 Structure of Polycystin-2
 Function of Polycystin-2
 Conclusions
 References
 

  1. Dalgaard OZ: Polycystic disease of the kidneys. In Diseases of the Kidney, edited by Strauss MB, Welt LG, Boston, Little Brown and Company, 1963, pp1223 -1258
  2. Gabow PA, Ikle DW, Holmes JH: Polycystic kidney disease: Progressive analysis of nonazotemic patients and family members. Ann Intern Med 101:238 -247, 1984
  3. Reeders ST, Keith T, Green P, Germino GG, Barton NJ, Lehmann OJ, Brown VA, Phipps P, Morgan J, Bear JC, et al.: Regional localization of the autosomal dominant polycystic kidney disease locus. Genomics 3:150 -155, 1988[Medline]
  4. Kimberling WJ, Kumar S, Gabow PA, Kenyon JB, Connolly CJ, Somlo S: Autosomal dominant polycystic kidney disease: Localization of the second gene to chromosome 4q13-q23. Genomics18 : 467-472,1993[Medline]
  5. Ravine D, Walker RG, Gibson RN, Forrest SM, Richards RI, Friend K, Sheffield LJ, Kincaid-Smith P, Danks DM: Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease. Lancet 340:1330 -1333, 1992[Medline]
  6. Nomura H, Turco AE, Pei Y, Kalaydjieva L, Schiavello T, Weremowicz S, Ji W, Morton CC, Meisler M, Reeders ST, Zhou J: Identification of PKDL, a novel polycystic kidney disease 2-like gene whose murine homologue is deleted in mice with kidney and retinal defects. J Biol Chem273 : 25967-25973,1998[Abstract/Free Full Text]
  7. The European Polycystic Kidney Disease Consortium: The polycystic kidney disease 1 gene encodes for a 14kb transcript and lies within a duplicated region on chromosome 16. Cell77 : 882-894,1994
  8. The International Polycystic Kidney Disease Consortium: Polycystic kidney disease: The complete structure of the pkd-1 gene and its protein. Cell 81:289 -298, 1995[Medline]
  9. Hughes J, Ward CJ, Aspinwall R, Butler R, Harris PC: Identification of a human homologue of the sea urchin receptor for egg jelly: A polycystic kidney disease-like protein. Hum Mol Genet8 : 543-549,1999[Abstract/Free Full Text]
  10. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris J, Reynolds D, Cai Y, Gabow P, Pierides A, Kimberling W, Breuning MH, Deltas CC, Peters DJM, Somlo S: PKD2, a gene for polycystic kidney disease that encodes an intergral membrane protein. Science272 : 1339-1342,1996[Abstract]
  11. Moy GW, Mendoza LM, Schulz JR, Swanson WJ, Glabe CG, Vacquier VD: The sea urchin sperm receptor for egg jelly is a modular protein with extensive homology to the human polycystic kidney disease protein, PKD1. J Cell Biol 133:809 -817, 1996[Abstract/Free Full Text]
  12. Sandford R, Sgotto B, Aparicio S, Brenner S, Vaudin M, Wilson RK, Chissoe S, Pepin K, Bateman A, Chothia C, Hughes J, Harris P: Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains. Hum Mol Genet 6:1483 -1489, 1997[Abstract/Free Full Text]
  13. Barr MM, Sternberg PW: A polycystic kidney-disease gene homologue required for male mating behaviour in C. elegans. Nature 401:386 -389, 1999[Medline]
  14. Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, Gamble V, Harris PC: The polycystic kidney disease 1(PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 10:151 -160, 1995[Medline]
  15. Geng L, Segal Y, Peissel B, Deng N, Pei Y, Carone F, Rennke HG, Glucksmann-Kuis AM, Schneider MC, Ericsson M, Reeders ST, Zhou J: Identification and localization of polycystin, the PKD1 gene product. J Clin Invest 98:2674 -2682, 1996[Medline]
  16. Wilson PD: Epithelial cell polarity and disease. Am J Physiol 272:F434 -F442, 1997[Abstract/Free Full Text]
  17. Ibraghimov-Beskrovnaya O, Dackowski WR, Foggensteiner L, Coleman N, Thiru S, Petry LR, Burn TC, Connors TD, Van Raay T, Bradley J, Qian F, Onuchic LF, Watnick TJ, Piontek K, Hakim RM, Landes GM, Germino GG, Sandford R, Klinger KW: Polycystin: In vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci USA 94:6397 -6402, 1997[Abstract/Free Full Text]
  18. Gay NJ, Packman LC, Weldon MA, Barna JC: A leucine-rich repeat peptide derived from the Drosophila Toll receptor forms extended filaments with a beta-sheet structure. FEBS Lett291 : 87-91,1991[Medline]
  19. Fukuda M, Hiraoka N, Yeh JC: C-type lectins and sialyl Lewis X oligosaccharides. Versatile roles in cell-cell interaction. J Cell Biol 147:467 -470, 1999[Abstract/Free Full Text]
  20. Bycroft M, Bateman A, Clarke J, Hamill SJ, Sandford R, Thomas RL, Chothia C: The structure of a PKD domain from polycystin-1: Implications for polycystic kidney disease. EMBO J18 : 297-305,1999[Medline]
  21. Wilson PD, Geng L, Li X, Burrow CR: The PKD-1-encoded protein, "polycystin-1", is a tyrosine-phosphorylated protein that co-localizes with {alpha}2-ß1 integrin in focal clusters in adherent renal epithelia. Lab Invest 79:1311 -1323, 1999[Medline]
  22. Palsson R, Sharma CP, Kim K, McLaughlin M, Brown D, Arnaout MA: Characterization and cell distribution of polycystin, the product of autosomal dominant polycystic kidney disease gene 1. Mol Med2 : 702-711,1996[Medline]
  23. Geng L, Segal Y, Pavlova A, Barros EJ, Lohning C, Lu W, Nigam SK, Frischauf AM, Reeders ST, Zhou J: Distribution and developmentally regulated expression of murine polycystin. Am J Physiol272 : F451-F459,1997[Abstract/Free Full Text]
  24. Van Adelsberg J, Chamberlain S, D'Agati V: Polycystin expression is temporally and spatially regulated during renal development. Am J Physiol 272:F602 -FF609, 1997[Abstract/Free Full Text]
  25. Ong AC, Ward CJ, Butler RJ, Biddolph S, Bowker C, Torra R, Pei Y, Harris PC: Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue. Am J Pathol 154:1721 -1729, 1999[Abstract/Free Full Text]
  26. Foggensteiner L, Bevan AP, Thomas R, Coleman N, Boulter C, Bradley J, Ibraghimov-Beskrovnaya O, Klinger K, Sandford R: Cellular and subcellular distribution of polycystin-2, the protein product of the PKD2 gene. J Am Soc Nephrol 11:814 -827, 2000[Abstract/Free Full Text]
  27. Kay BK, Williamson MP, Sudol M: The importance of being proline: The interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J 14:231 -241, 2000[Abstract/Free Full Text]
  28. Li HP, Geng L, Burrow CR, Wilson PD: Identification of phosphorylation sites in the PKD1-encoded protein C- terminal domain. Biochem Biophys Res Commun 259:356 -363, 1999[Medline]
  29. Sudol M, Chen HI, Bougeret C, Einbond A, Bork P: Characterization of a novel protein-binding module—The WW domain. FEBS Lett 369: 67-71,1995[Medline]
  30. Parnell SC, Magenheimer BS, Maser RL, Rankin CA, Smine A, Okamoto T, Calvet JP: The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. Biochem Biophys Res Commun 251:625 -631, 1998[Medline]
  31. Lupas A: Coiled coils: New structures and new functions. Trends Biochem Sci 21:375 -382, 1996[Medline]
  32. Wilson PD, Sherwood AC, Palla K, Du J, Watson R, Norman JT: Reversed polarity of Na+-K+-ATPase: Mislocation to apical plasma membranes in polycystic kidney disease epithelia. Am J Physiol260 : F420-F430,1991[Abstract/Free Full Text]
  33. Avner ED, Sweeney WE Jr, Nelson WJ: Abnormal sodium pump distribution during renal tubulogenesis in congenital murine polycystic kidney disease. Proc Natl Acad Sci USA89 : 7447-7451,1992[Abstract/Free Full Text]
  34. Du J, Wilson PD: Abnormal polarized location of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am J Physiol 269:C487 -C495, 1995[Abstract/Free Full Text]
  35. Charron AJ, Nakamura S, Bacallao R, Wandinger-Ness A: Compromised cytoarchitecture and polarized trafficking in autosomal dominant polycystic kidney disease cells. J Cell Biol149 : 111-124,2000[Abstract/Free Full Text]
  36. Qian F, Germino J, Cai Y, Zhang X, Somlo S, Germino G: PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet 16:179 -183, 1997[Medline]
  37. Tsiokas L, Kim E, Arnould T, Sukhatme V, Walz G: Homo- and hetero-dimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci USA 94:6965 -6970, 1997[Abstract/Free Full Text]
  38. Ward CJ, Turley H, Ong AC, Comley M, Biddolph S, Chetty R, Ratcliffe PJ, Gatter K, Harris PC: Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult and polycystic kidney. Proc Natl Acad Sci USA93 : 1524-1528,1996[Abstract/Free Full Text]
  39. Ong AC, Harris PC, Biddolph S, Bowker C, Ward CJ: Characterisation and expression of the PKD-1 protein, polycystin, in renal and extrarenal tissues. Kidney Int 55:2091 -2116, 1999[Medline]
  40. Burrow CR, Thornton K, Hyink D, Wilson PD: Developmentally regulated early expression of the PKD-1-encoded gene product "polycystin-1" in normal human kidneys. J Am Soc Nephrol 8: 370A,1997
  41. Lu W, Peissel B, Babakhanlou H, Pavlova A, Geng L, Fan X, Larson C, Brent G, Zhou J: Perinatal lethality with kidney and pancreas defects in mice with a targeted Pkd1 mutation. Nat Genet17 : 179-181,1997[Medline]
  42. Lu W, Fan X, Basora N, Babakhanlou H, Law T, Rifai N, Harris PC, Perez-Atayde AR, Rennke HG, Zhou J: Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes [Letter]. Nat Genet21 : 160-161,1999[Medline]
  43. Kim K, Drummond I, Ibraghimov-Beskrovnaya O, Klinger K, Arnaout MA: Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci USA 97:1731 -1736, 2000[Abstract/Free Full Text]
  44. Wu G, D'Agati V, Cai Y, Markowitz G, Park JH, Reynolds DM, Maeda Y, Le TC, Hou H Jr, Kucherlapati R, Edelmann W, Somlo S: Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell93 : 177-188,1998[Medline]
  45. Wilson PD, Dillingham MA, Breckon R, Anderson RJ: Defined human renal tubular epithelia in culture: Growth, characterization and hormonal response. Am J Physiol 248:436 -443, 1985
  46. Wilson PD: In vitro methods in renal research. In: Pediatric Nephrology, 4th Ed, edited by Barratt TM, Avner ED, Harmon WE, Baltimore, Lippincott, Williams & Wilkins,1999 , pp 269-281
  47. Wilson PD, Burrow CR: Cystic diseases of the kidney: Role of adhesion molecules in normal and abnormal tubulogenesis. Exp Nephrol 7:114 -124, 1999[Medline]
  48. Geng L, Burrow CR, Li HP, Wilson PD: Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation. Biochim Biophys Acta1535 : 21-35,2000[Medline]
  49. Wilson PD, Burrow CR: Autosomal dominant polycystic kidney disease. Adv Nephrol 21:125 -142, 1992
  50. Wilson PD: Pathogenesis of polycystic kidney disease: Altered cellular function. In Polycystic Kidney Diseases, edited by Watson ML, Torres VE, Oxford, Oxford Medical Publications,1996 , pp 125-163
  51. Wilson PD, Falkenstein D: The pathology of human renal cystic disease. Curr Top Pathol 88:1 -50, 1995[Medline]
  52. Burrow CR, Devuyst O, Li X, Gatti L, Wilson PD: Expression of the ß2-subunit and apical localization of Na+-K+- ATPase in metanephric kidney. Am J Physiol 277:F391 -F403, 1999[Abstract/Free Full Text]
  53. Wilson PD, Devuyst O, Li X, Gatti L, Falkenstein D, Robinson S, Fambrough D, Burrow CR: Apical plasma membrane mispolarization of NaK-ATPase in polycystic kidney disease epithelia is associated with aberrant expression of the ß2 isoform. Am J Pathol156 : 253-268,2000[Abstract/Free Full Text]
  54. Burrow CR, Wilson SJ, Wilson PD: Developmental regulation of Erb-B2 in human kidney organogenesis with persistent expression in ADPKD. Mol Biol Cell 8:441a , 1997
  55. Hynes RO: Integrins: Versatility modulation and signaling in cell adhesion. Cell 69:11 -25, 1992[Medline]
  56. Aplin AE, Howe AK, Juliano RL: Cell adhesion molecules, signal transduction and cell growth. Curr Opin Cell Biol11 : 737-744,1999[Medline]
  57. Parsons JT, Parsons SJ: Src family protein tyrosine kinases: Cooperating with growth factor and adhesion signaling pathways. Curr Opin Cell Biol 9:187 -192, 1997[Medline]
  58. Giancotti FG, Ruoslahti E: Integrin signaling. Science 285:1028 -1032, 1999[Abstract/Free Full Text]
  59. Bianchi E, Denti S, Granata A, Bossi G, Geginat J, Villa A, Rogge L, Pardi R: Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity. Nature404 : 617-621,2000[Medline]
  60. Clark EA, Brugge JS: Integrins and signal transduction pathways: The road taken. Science 268:233 -239, 1995[Abstract/Free Full Text]
  61. Hanks SK, Polte TR: Signaling through focal adhesion kinase. Bioessays 19:137 -145, 1997[Medline]
  62. Cary LA, Han DC, Polte TR, Hanks SK, Guan JL: Identification of p130Cas as a mediator of focal adhesion kinase-promoted cell migration. J Cell Biol 140:211 -221, 1998[Abstract/Free Full Text]
  63. Angers-Loustau A, Cote JF, Charest A, Dowbenko D, Spencer S, Lasky LA, Tremblay ML: Protein tyrosine phosphatase-PEST regulates focal adhesion disassembly, migration, and cytokinesis in fibroblasts. J Cell Biol 144:1019 -1031, 1999[Abstract/Free Full Text]
  64. Gilmore AP, Romer LH: Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell 7:1209 -1224, 1996[Abstract]
  65. Shen Y, Schaller MD: Focal adhesion targeting: The critical determinant of FAK regulation and substrate phosphorylation. Mol Biol Cell 10:2507 -2518, 1999[Abstract/Free Full Text]
  66. Yap AS, Brieher WM, Gumbiner BM: Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol 13: 119-146,1997[Medline]
  67. Gumbiner BM: Regulation of cadherin adhesive activity. J Cell Biol 148:399 -404, 2000[Abstract/Free Full Text]
  68. Willert K, Nusse R: Beta-catenin: A key mediator of Wnt signaling. Curr Opin Genet Dev 8:95 -102, 1998[Medline]
  69. Huber O, Bierkamp C, Kemler R: Cadherins and catenins in development. Curr Opin Cell Biol8 : 685-691,1996[Medline]
  70. Kim E, Arnould T, Sellin L, Benzing T, Comella N, Kocher O, Tsiokas L, Sukhatme VP, Walz G: Interaction between RGS7 and polycystin. Proc Natl Acad Sci USA 96:6371 -6376, 1999[Abstract/Free Full Text]
  71. Arnould T, Kim E, Tsiokas L, Jochimsen F, Gruning W, Chang JD, Walz G: The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1. J Biol Chem273 : 6013-6018,1998[Abstract/Free Full Text]
  72. Kim E, Arnould T, Sellin LK, Benzing T, Fan MJ, Gruning W, Sokol SY, Drummond I, Walz G: The polycystic kidney disease 1 gene product modulates Wnt signaling. J Biol Chem 274:4947 -4953, 1999[Abstract/Free Full Text]
  73. Huan Y, van Adelsberg J: Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J Clin Invest 104:1459 -1468, 1999[Medline]
  74. Geng L, Burrow CR, Bloswick B, Wilson PD: Polycystin-1 is associated with focal adhesion proteins and the actin cytoskeleton to form large multi-protein complexes. J Am Soc Nephrol9 : 374A,1998
  75. Parnell SC, Magenheimer BS, Maser RL, Calvet JP: Identification of the major site of in vitro PKA phosphorylation in the polycystin-1 C-terminal cytosolic domain. Biochem Biophys Res Commun259 : 539-543,1999[Medline]
  76. Li X, Burrow CR, Li HP, Wilson PD: Protein kinase X gene products have specific functions in renal development and autosomal dominant polycystic kidney disease (ADPKD). J Am Soc Nephrol10 : 429A,1999
  77. Tsiokas L, Arnould T, Zhu C, Kim E, Walz G, Sukhatme VP: Specific association of the gene product of PKD2 with the TRPC1 channel. Proc Natl Acad Sci USA 96:3934 -3939, 1999[Abstract/Free Full Text]
  78. Chen XZ, Vassilev PM, Basora N, Peng JB, Nomura H, Segal Y, Brown EM, Reeders ST, Hediger MA, Zhou J: Polycystin-L is a calcium-regulated cation channel permeable to calcium ions. Nature401 : 383-386,1999[Medline]
  79. Gallagher AR, Cedzich A, Gretz N, Somlo S, Witzgall R: The polycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the actin cytoskeleton. Proc Natl Acad Sci USA 97:4017 -4022, 2000[Abstract/Free Full Text]
  80. Klemke RL, Leng J, Molander R, Brooks PC, Vuori K, Cheresh DA: CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. J Cell Biol140 : 961-972,1998[Abstract/Free Full Text]
  81. Petit V, Boyer B, Lentz D, Turner CE, Thiery JP, Valles AM: Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells. J Cell Biol 148:957 -970, 2000[Abstract/Free Full Text]
  82. Vuori K, Ruoslahti E: Connections count in cell migration. Nat Cell Biol 1:E85 -E87, 1999[Medline]
  83. Burrow CR, Wilson SJ, Wilson PD: Developmental regulation of erb-B2 in human kidney organogenesis with persistent expression in autosomal dominant polycystic kidney disease. Mol Biol Cell8 : 441A,1997
  84. Worton R: Muscular dystrophies: Disease of the dystrophin-glycoprotein complex. Science270 : 755-756,1995[Abstract/Free Full Text]
  85. Hemler ME: Dystroglycan versatility. Cell97 : 543-546,1999[Medline]
  86. Hildebrandt F: Identification of a gene for nephronophthisis. Nephrol Dial Transplant 13:1334 -1336, 1998[Free Full Text]
  87. Lo SH, Yu Q, Degenstein L, Chen LB, Fuchs E: Progressive kidney degeneration in mice lacking tensin. J Cell Biol136 : 1349-1361,1997[Abstract/Free Full Text]
  88. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mathis BJ, Rodriguez-Perez JC, Allen PG, Beggs AH, Pollak MR: Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24:251 -256, 2000[Medline]
  89. Nobes CD, Hall A: Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol144 : 1235-1244,1999[Abstract/Free Full Text]
Received for publication May 2, 2000. Accepted for publication September 26, 2000.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Olteanu, M. B. Hovater, and E. M. Schwiebert
Intraluminal autocrine purinergic signaling within cysts: implications for the progression of diseases that involve encapsulated cyst formation
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F11 - F14.
[Full Text] [PDF]


Home page
J. Biol. Chem.